BioMed Research International / 2014 / Article / Fig 13

Research Article

Antimicrobial and Controlled Release Studies of a Novel Nystatin Conjugated Iron Oxide Nanocomposite

Figure 13

MTT assays of a normal fibroblast (3T3) cell line after 72 hours of treatment with free nystatin, MNPs, CS-MNP, and Nyst-CS-MNP at different concentrations.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.